InvestSMART

Cynata Therapeutics Limited (ASX: CYP) - Announcements

- Current share price for CYP : $0.013

ASX company news and announcements for Cynata Therapeutics Limited (CYP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cynata Therapeutics Limited (CYP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cynata Therapeutics Limited (CYP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cynata Therapeutics Limited (CYP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Notification of cessation of securities - CYP 10 Jul 2026 8:38AM $0.014 $0.013 fallen by 7.14%
$3 Final Director's Interest Notice 6 Jul 2026 8:37AM $0.013 $0.013 fallen by 0%
$3 Board, Management Changes, Expenditure Reductions, RDTI Loan 6 Jul 2026 8:35AM $0.013 $0.013 fallen by 0%
$3 Ceasing to be a substantial holder 2 Jul 2026 6:31PM $0.014 $0.013 fallen by 7.14%
$3 Change in substantial holding 2 Jul 2026 8:15AM $0.014 $0.013 fallen by 7.14%
$3 Becoming a substantial holder 30 Jun 2026 8:57AM $0.012 $0.013 risen by 8.33%
$3 Ceasing to be a substantial holder 23 Jun 2026 3:47PM $0.016 $0.013 fallen by 18.75%
$3 Investor Webinar 22 Jun 2026 8:19AM $0.018 $0.013 fallen by 27.78%
$3 Reinstatement to Official Quotation 19 Jun 2026 9:22AM $0.260 $0.013 fallen by 95%
$3 CYP-004 Osteoarthritis Trial Results 19 Jun 2026 9:22AM $0.260 $0.013 fallen by 95%
$3 CYP-001 GvHD Trial Primary Evaluation Results 17 Jun 2026 12:05PM $0.260 $0.013 fallen by 95%
$3 Suspension from Quotation 16 Jun 2026 8:53AM $0.260 $0.013 fallen by 95%
$3 Trading Halt 12 Jun 2026 9:46AM $0.260 $0.013 fallen by 95%
$3 EU Positive Opinion on CYP-001 Paediatric Investigation Plan 3 Jun 2026 8:48AM $0.275 $0.013 fallen by 95.27%
$3 WHO Selects Proposed INN for Cymerus MSCs 29 May 2026 8:56AM $0.255 $0.013 fallen by 94.90%
$3 Expected Timing of Clinical Trial Results 27 May 2026 8:54AM $0.260 $0.013 fallen by 95%
$3 Cleansing Notice 8 May 2026 9:01AM $0.315 $0.013 fallen by 95.87%
$3 Application for quotation of securities - CYP 8 May 2026 8:57AM $0.315 $0.013 fallen by 95.87%
$3 Proposed issue of securities - CYP 4 May 2026 9:05AM $0.323 $0.013 fallen by 95.97%
$3 Cynata Secures Commitments for $1.5m Placement 4 May 2026 9:05AM $0.323 $0.013 fallen by 95.97%
$3 March 2026 Quarterly Activity Report & Appendix 4C 30 Apr 2026 10:00AM $0.323 $0.013 fallen by 95.97%
$3 Trading Halt 30 Apr 2026 9:03AM $0.323 $0.013 fallen by 95.97%
$3 Notification of cessation of securities - CYP 7 Apr 2026 8:31AM $0.295 $0.013 fallen by 95.59%
$3 Last Visit in GvHD Trial Completed 30 Mar 2026 8:58AM $0.300 $0.013 fallen by 95.67%
$3 Appendix 4D & Half-Year Financial Statements 26 Feb 2026 3:43PM $0.360 $0.013 fallen by 96.39%

1 - 25 of 698 results

Page 1 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.